The most common adverse events associated with gabapentin treatment, compared with placebo, are dizziness (19.1% vs. 6.6%), somnolence (14.1% vs. 5.2%), ataxia or gait disorder (14.0% vs. 2.2%), and peripheral edema (6.6% vs. 1.5%).22 A systematic review showed that about 1% of the general population misused gabapentin for recreational purposes, self-medication, or intentional self-harm, either alone or in combination with other substances (including alcohol).56
